Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Expert Opinion on Biological Therapy|June 2, 2012
Proliferative human cell sources applied as biocomponent in bioartificial livers: a reviewGeert A A Nibourg, Robert A F M Chamuleau, Thomas M van Gulik, et al.
Annals of Surgery|July 28, 2012
Physiological and biochemical basis of clinical liver function tests: a reviewLisette T Hoekstra, Wilmar de Graaf, Geert A A Nibourg, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 7, 2010
Stable overexpression of pregnane X receptor in HepG2 cells increases its potential for bioartificial liver applicationGeert A A Nibourg, Maarten T Huisman, Tessa V van der Hoeven, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 8, 2013
Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-bioartificial liverGeert A A Nibourg, Ruurdtje Hoekstra, Tessa V van der Hoeven, et al.
Biotechnology and Bioengineering|June 26, 2012
Perfusion flow rate substantially contributes to the performance of the HepaRG-AMC-bioartificial liverGeert A A Nibourg, Justin D Boer, Tessa V van der Hoeven, et al.
The International Journal of Biochemistry & Cell Biology|June 18, 2013
Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactorGeert A A Nibourg, Ruurdtje Hoekstra, Tessa V van der Hoeven, et al.
The International Journal of Artificial Organs|October 16, 2012
The effect of rat acute-liver-failure plasma on HepaRG cellsRuurdtje Hoekstra, Geert A A Nibourg, Tessa V van der Hoeven, et al.
The International Journal of Biochemistry & Cell Biology|July 6, 2011
The HepaRG cell line is suitable for bioartificial liver applicationRuurdtje Hoekstra, Geert A A Nibourg, Tessa V van der Hoeven, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 15, 2012
Phase 1 and phase 2 drug metabolism and bile acid production of HepaRG cells in a bioartificial liver in absence of dimethyl sulfoxideRuurdtje Hoekstra, Geert A A Nibourg, Tessa V van der Hoeven, et al.
Plos One|June 22, 2012
Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failureGeert A A Nibourg, Robert A F M Chamuleau, Tessa V van der Hoeven, et al.
Pageof 1